Lin Miao
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Gastroenterology top 5%
Papers in
- Surgery 43
- Cholangiocarcinoma and Gallbladder Cancer Studies 11
- Pediatric Hepatobiliary Diseases and Treatments 9
- Esophageal and GI Pathology 7
-
- RNA modifications and cancer 13
- Co-authors
- Quanpeng Li (30 shared papers)Xianxiu Ge (29 shared papers)Xueting Deng (15 shared papers)Simin Tang (2 shared papers)Jian Zhou (1 shared paper)Mian Wu (6 shared papers)Yide Mei (4 shared papers)Dong‐Feng Wu (16 shared papers)
- Journals
- Lipids in Health and Disease (10 papers)Medicine (5 papers)Scientific Reports (5 papers)Surgical Endoscopy (4 papers)Fermentation (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lin Miao
153 papers receiving 2.9k citations
Lin Miao's Hit Papers
Peers
Comparison fields: 5 of 140
- Cancer Research 672
- Gastroenterology 134
- Molecular Biology 1.1k
- Biochemistry 90
- Oncology 341
Countries citing papers authored by Lin Miao
This map shows the geographic impact of Lin Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Miao more than expected).
Fields of papers citing papers by Lin Miao
This network shows the impact of papers produced by Lin Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Miao. The network helps show where Lin Miao may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Miao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects Hit paper breakdown → | 2019 | 500 |
| 2 | 2020 | 159 | |
| 3 | 2013 | 115 | |
| 4 | 2006 | 100 | |
| 5 | 2014 | 85 | |
| 6 | 2018 | 63 | |
| 7 | 2015 | 55 | |
| 8 | 2017 | 55 | |
| 9 | 2014 | 51 | |
| 10 | 2014 | 48 | |
| 11 | 2015 | 46 | |
| 12 | 2011 | 45 | |
| 13 | 2020 | 41 | |
| 14 | 2014 | 41 | |
| 15 | 2013 | 40 | |
| 16 | 2010 | 40 | |
| 17 | 2018 | 40 | |
| 18 | Regulation of endothelial IGFBP-3 synthesis and secretion by IGF-I and TGF-beta. | 1996 | 35 |
| 19 | 2021 | 34 | |
| 20 | 2015 | 33 |
About Lin Miao
Lin Miao is a scholar working on Surgery, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 166 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (16 papers), Gallbladder and Bile Duct Disorders (16 papers), RNA modifications and cancer (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), MicroRNA in disease regulation (10 papers), Pediatric Hepatobiliary Diseases and Treatments (9 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Esophageal and GI Pathology (7 papers). The work is most often cited by research in Cancer Research (672 citations), Gastroenterology (134 citations), Molecular Biology (1.1k citations), Biochemistry (90 citations) and Oncology (341 citations). Lin Miao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Quanpeng Li, Xianxiu Ge, Xueting Deng, Simin Tang, Jian Zhou, Mian Wu, Yide Mei, Dong‐Feng Wu, Lynn Htet Htet Aung and Rui‐Xing Yin. Their work appears in journals such as Lipids in Health and Disease, Medicine, Scientific Reports, Surgical Endoscopy and Fermentation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.